SCHEMBL18645249

SCHEMBL18645249

CNC(=O)C(C)(C)n1cc(C)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 3/20 0.41
MAP4K4 O95819 1/20 0.39
MAP4K1 Q92918 1/20 0.38
NOS1 P29475 1/20 0.34
PIK3CA P42336 1/20 0.34
ALDH1A1 P00352 2/20 0.33
FGFR1 P11362 1/20 0.33
FGFR2 P21802 1/20 0.33
FGFR4 P22455 1/20 0.33
FGFR3 P22607 1/20 0.33
KDR P35968 1/20 0.33
TGM2 P21980 1/20 0.33
TGM1 P22735 1/20 0.33
LMNA P02545 2/20 0.32
KDM4E B2RXH2 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
HTT P42858 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20910169 0.81 ALDH1A1 (0.33) NOS1ALDH1A1TGM2TGM1LMNA
SCHEMBL22298683 0.81 MAP4K4 (0.38) LRRK2MAP4K4MAP4K1PIK3CAFGFR1
SCHEMBL20519689 0.81 MAP4K4 (0.38) LRRK2MAP4K4MAP4K1PIK3CAALDH1A1
SCHEMBL25460776 0.81 ELANE (0.41) LRRK2MAP4K4MAP4K1PIK3CAALDH1A1
SCHEMBL15650642 0.81 MAP4K4 (0.41) LRRK2MAP4K4MAP4K1PIK3CAFGFR1
SCHEMBL12837968 0.79 LMNA (0.44) NOS1ALDH1A1TGM2TGM1LMNA
SCHEMBL15601835 0.79 EGLN1 (0.37) LRRK2ALDH1A1LMNANPC1RAB9A
SCHEMBL13390165 0.79 HCRTR1 (0.38) NOS1ALDH1A1TGM2TGM1LMNA
SCHEMBL19939682 0.78 MAP4K4 (0.37) LRRK2MAP4K4MAP4K1PIK3CAFGFR1
SCHEMBL19943507 0.78 MAP4K4 (0.37) LRRK2MAP4K4MAP4K1PIK3CAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3347361-B1 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE HOFFMANN LA ROCHE (CH) 2020-08-05 EP disclosed
WO-2017042182-A1 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2017-03-16 WO disclosed